Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Mar 15;38(4):599-601.
doi: 10.1097/QAD.0000000000003757. Epub 2024 Feb 29.

Reassessing the emphasis on limited options in antiretroviral treatment

Affiliations
Editorial

Reassessing the emphasis on limited options in antiretroviral treatment

Mauro Zaccarelli. AIDS. .
No abstract available

PubMed Disclaimer

Comment on

  • Heavy antiretroviral exposure and exhausted/limited antiretroviral options: predictors and clinical outcomes.
    Mocroft A, Pelchen-Matthews A, Hoy J, Llibre JM, Neesgaard B, Jaschinski N, Domingo P, Rasmussen LD, Günthard HF, Surial B, Öllinger A, Knappik M, de Wit S, Wit F, Mussini C, Vehreschild J, Monforte AD, Sonnerborg A, Castagna A, Anne AV, Vannappagari V, Cohen C, Greaves W, Wasmuth JC, Spagnuolo V, Ryom L; for the RESPOND cohort collaboration. Mocroft A, et al. AIDS. 2024 Mar 15;38(4):497-508. doi: 10.1097/QAD.0000000000003798. Epub 2023 Dec 8. AIDS. 2024. PMID: 38079588

References

    1. Lucas GM, Gallant JE, Moore RD. Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing . AIDS 2004; 18:1539–1548.
    1. Hogg RS, Bangsberg DR, Lima VD, Alexander C, Bonner S, Yip B, et al. Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART . PLoS Med 2006; 3:e356.
    1. Zaccarelli M, Forbici F, Lorenzini P, Ceccherini-Silberstein F, Tozzi V, Trotta MP, et al. Continuous evidence of fast HIV disease progression related to class-wide resistance to antiretroviral drugs: a 6-year follow-up analysis of a large observational database . AIDS 2007; 21:1824–1826.
    1. Mocroft A, Pelchen-Matthews A, Hoy J, Llibre JM, Neesgaard B, Jaschinski N, et al. Heavy antiretroviral exposure and exhausted/limited antiretroviral options: predictors and clinical outcomes . AIDS 2024; 38:497–508.
    1. Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem AV, et al. ATHENA observational cohort. Future challenges for clinical care of an ageing population infected with HIV: a modelling study . Lancet Infect Dis 2015; 15:810–818.

MeSH terms

Substances